Search results for "" 2292 results found
Sort By
By Date
By Relevance
-
IP Cases & Articles
Groundless threat provisions - what are they for?
Groundless threat provisions under UK law are unique in the sense that they aim to safeguard the interests of both IP right holders and third parties at the same time. On one hand IP right holders may be wondering "what steps can I take to protect my IP rights? If… -
IP Cases & Articles
Patent litigation funding and insurance
For parties involved in patent litigation, the potential costs and financial risks involved can often be a significant factor in dictating strategy. In some cases, concerns about costs risks or a lack of funding may even be a complete barrier to commencing litigation against known infringers. -
IP Cases & Articles
Courts take a fresh look at toxic priorities
The concept of multiple priorities, sometimes referred to as partial priority or split priority, has long been a matter for debate in European patent law (and thus UK patent law [see end note 1]). However, interest in how the law governing multiple priorities is to be interpreted has been stimulated… -
IP Cases & Articles
EPO publishes new G3/14 decision
The EPO's Enlarged Board of Appeal have made available a copy of their decision on this case, which considers the issue of whether the Opposition Division are allowed (or even obliged) to consider the clarity of an amendment in which a dependent claim is 'inserted' into an independent claim. -
IP Cases & Articles
Unitary patent: renewal fees disclosed
The potential cost of the European patent with unitary effect (the unitary patent), compared to the cost of a standard bundle of European patents, has been the subject of much debate - since over the lifetime of a patent, the renewal fees can account for a considerable proportion of the… -
IP Cases & Articles
Second medical use and skinny label claims in the UK
In our most recent patent newsletter, we reported the decision of Mr Justice Arnold in Warner–Lambert Company, LLC v Actavis, handed down on 21 January, 2015 in which he dismissed an application for an interim injunction under a second medial patent for Pregabalin. -
IP Cases & Articles
IP protection for invasive technology innovation
The expansion of the wearable technology sector has been meteoric. In 2010, the sector was worth around $6 million, whilst it is estimated that by 2018 the sector will be worth over $12 billion. This 2000-fold increase in value over just eight years shows that many technological companies are investing… -
IP Cases & Articles
Signs of divergence in Europe for skinny labels
The recent High Court judgment in Warner Lambert v Actavis & others provides a first decision in the UK concerning the infringement of Swiss form second medical use claims. This sentence needs to be well-qualified as Justice Arnold himself did with the judgment, in that his decision is possibly applicable… -
IP Cases & Articles
CJ definition of human embryo: ISCC parthenote case
In continuation of our articles concerning the patenting of stem cells, we report here on the recent ruling by the Court of Justice of the European Union (CJ) (Case C-364/13) regarding whether human parthenotes fall under the definition of a human embryo under the Biotechnology Directive 98/44. -
IP Cases & Articles
Worldwide patent data analysis - IP5 statistics report
You may not be aware of the IP5 offices, but given the context of this newsletter you will not be surprised that the "IP" indicates "intellectual property". The "5" offices were originally three in 1983: Europe, Japan and the US, then four in 2008 with the inclusion of Korea, and…
Page 79 of 230
Previous Next